Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine

Malaria Journal

Volumn 2, Issue , 2003, Pages 1-12

  Warhurst, David C ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; CHLOROQUINE; DEETHYLAMODIAQUINE; MICROORGANISM PROTEIN; PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER PROTEIN; UNCLASSIFIED DRUG; VERAPAMIL; ANTIMALARIAL AGENT; CINCHONA ALKALOID; CINCHONIDINE; CINCHONINE; DIHYDROQUINIDINE; EPICINCHONIDINE; EPICINCHONINE; EPIQUINIDINE; EPIQUININE; HEMATIN; HYDROQUININE; OCTANOL; QUINIDINE; QUININE; WATER;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENTIATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HAPLOTYPE; HYDROPHOBICITY; IC 50; NONHUMAN; PHYSICAL CHEMISTRY; PLASMODIUM FALCIPARUM; SEQUENCE ANALYSIS; ANTIMALARIAL ACTIVITY; CHEMICAL PARAMETERS; COMPLEX FORMATION; DIMERIZATION; DRUG STRUCTURE; ERYTHROCYTE MEMBRANE; IONIZATION CONSTANT; ISOMER; LIPOPHILICITY; MEMBRANE TRANSPORT; MOLECULAR MODEL; PROTEIN SYNTHESIS INHIBITION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TRANSPORT KINETICS;

EID: 3042555873     PISSN: 14752875     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2875-2-1     Document Type: Article

References (30)

1. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ and Su XZ: Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002, 418:320-323.
2. Trape JF: The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg 2000, 64(suppl):12-17.
3. Homewood CA, Warhurst DC, Peters W and Baggaley VC: Lysosomes, pH and the anti-malarial action of chloroquine. Nature 1972, 235:50-52.
4. Chou AC, Chevli R and Fitch CD: Ferriprotoporphyrin IX fulfils the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry 1980, 19:1543-1549.
5. Pagola S, Stephens PW, Bohle DS, Kosar AD and Madsen SK: The structure of malaria pigment beta-haematin. Nature 2000, 404:307-310.
6. Foote SJ, Kyle DJ, Martin SK, Oduola AMJ, Forsyth K, Kemp DJ and Cowman AJ: Several alleles of the multi-drug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 1990, 345:255-258.
7. Warhurst DC: A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 2001, 344:299-302.
8. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LMB, Sidhu AS, Naude B, Deitsch KW, Su X, Wootton JC, Roepe PD and Wellems TE: Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Molecular Cell 2000, 6:861-871.
9. Nomura T, Carlton JM, Baird JK, del Portillo HA, Fryauff DJ, Rathore D, Fidock DA, Su X, Collins WE, McCutchan TF, Wootton JC and Wellems TE: Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J Infect Dis 2001, 183:1653-1661.
10. Dutzler R, Campbell EB, Cadene M, Chait BT and MacKinnon R: X-ray structure of a ClC chloride channel at 3.0 Å reveals the molecular basis of anion selectivity. Nature 2002, 415:287-294.
11. Zhang H, Howard EM and Roepe PD: Analysis of the antimalarial drug resistance protein Pfcrt in yeast. J Biol Chem 2002, 277:49767-49775.
12. Ursos LM, DuBay KF and Roepe PD: Antimalarial drugs influence the pH dependent solubility of heme via apparent nucleation phenomena. Mol Biochem Parasitol 2001, 112:11-17.
13. Cooper RA, Ferdig MT, Su XZ, Ursos LM, Mu J, Nomura T, Fujioka H, Fidock DA, Roepe PD and Wellems TE: Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol Pharmacol 2002, 61:35-42.
14. Krogstad DJ, Gluzman IY, Kyle DE, Oduola AM, Martin SK, Milhous WK and Schlesinger PH: Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 1987, 238:1283-1285.
15. Bray PG, Howells RE, Ritchie GY and Ward SA: Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. A correlation of chloroquine sensitivity with energy-dependent drug accumulation. Biochem Pharmacol 1992, 44:1317-1324.
16. Sidhu AB, Verdier-Pinard D and Fidock DA: Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 2002, 298:210-213.
17. Churchill FC, Patchen LC, Campbell CC, Schwartz IK, Nguyen-Dinh P and Dickinson CM: Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci 1985, 36:53-62.
18. Childs GE, Boudreau EF, Milhous WK, Wimonwattratee T, Pooyindee N, Pang L and Davidson DE Jr: A comparison of the in vitro activities of amodiaquine and desethylamodiaquine against isolates of Plasmodium falciparum. Am J Trop Med Hyg 1989, 40:7-11.
19. Mehlotra RK, Fujioka H, Roepe PD, Janneh O, Ursos LM, Jacobs-Lorena V, McNamara DT, Bockarie MJ, Kazura JW, Kyle DE, Fidock DA and Zimmerman PA: Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc Natl Acad Sci U S A 2001, 98:12689-12694.
20. Galvao ALA, Gusmao HH, Juarez E, Schmid AW and de Mello: Malaria no Amapa. Observacoes sobre o comportamento anomalo do Plasmodium falciparum em face do tratamento pelas 4-aminoquinolinas. Archos Fac Hig Saude Pub Univ S. Paulo 1961, 15/16:201-244.
21. Young MD: Amodiaquine and hydroxychloroquine-resistance in Plasmodium falciparum. Am J Trop Med Hyg 1961, 10:689-693.
22. Eisenberg D: Three-dimensional structure of membrane and surface proteins. Annu Rev Biochem 1984, 53:595-623.
23. Martin SK, Oduola AM and Milhous WK: Reversal of chloroquine-resistance in Plasmodium falciparum. Science 1987, 235:899-901.
24. Kaschula CH, Egan TJ, Hunter R, Basilico N, Parapini S and Taramelli D: Structure-activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position. J Med Chem 2002, 45:3531-3539.
25. Warhurst DC, Craig JC and Adagu IS: Lysosomes and drug-resistance in malaria. Lancet 2002, 360:1527-1529.
26. Bray PG, Hawley SR, Mungthin M and Ward SA: Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. Mol Pharmacol 1996, 50:1559-1566.
27. Reed MB, Saliba KJ, Caruana SR, Kirk K and Cowman AF: Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000, 402:906-909.
28. Lim P, Chy S, Ariey F, Incardona S, Chim P, Sem R, Denis MB, Hewitt S, Hoyer S, Socheat D, Mercereau-Pujilon O and Fandeur T: Pfcrt Polymorphism and Chloroquine Resistance in Plasmodium falciparum strains isolated in Cambodia. Antimicrob Ag Chemother 2003, 47:87-94.
29. Significance limits for r when population correlation coefficient is zero. Documenta Geigy Scientific Tables. 6th edition. Edited by: Diem K. Giegy SA: Basle: p61. This Table enables it to be decided without calculation whether a correlation coefficient differs significantly from zero.
30. Warhurst DC, Craig JC, Adagu IS, Meyer DE and Lee SY: The relationship of physico-chemical properties and structure to the differential antiplasmodial activity of the Cinchona alkaloids. in press. http://www.malariajournal.com/content/2/1/26